XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net sales $ 1,939,542 $ 1,984,660 $ 639,893
Cost of sales 291,739 336,419 432,634
Gross profit 1,647,803 1,648,241 207,259
Operating expenses:        
Selling and marketing 32,349 49,160 66,171
General and administrative 1,716,060 625,067 2,660,300 2,210,097
Research and development 47,419 113,294
Vendor liability forgiveness, net of asset transfers 2,200,929
Total operating expenses 1,748,409 625,067 2,756,879 4,590,491
Operating loss (100,606) (625,067) (1,108,638) (4,383,232)
Other income (expense):        
Interest income (expense), net (3,246) (8,673) 82
Foreign currency exchange loss (8,948) (9,079)
Total other income (expense) (12,194) (17,752) 82
Loss before income taxes (112,800) (625,067) (1,126,390) (4,383,150)
Income tax expense (benefit) 140,185 140,185 (11,216)
Net loss $ (252,985) $ (625,067) $ (1,266,575) $ (4,371,934)
Net loss per share:        
Net loss per share, Basic $ (0.04) $ (0.21) $ (0.25) $ (1.47)
Net loss per share, Diluted $ (0.04) $ (0.21) $ (0.25) $ (1.47)
Basic weighted average common and common equivalent shares 6,295,961 3,022,805 5,037,981 2,972,118
Diluted weighted average common and common equivalent shares 6,295,961 3,022,805 5,037,981 2,972,118